| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7bae7cf399c53b51787e575edaf8b820 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4737 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F17-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06N3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06N3-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-539
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-721 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06N3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-539
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06N3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F17-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52 |
| filingDate |
2020-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_342777446e34a4c3f55b9fd89684573e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b072485cb98c25eebe0c03957d43c15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd35bd156491b379bbff38be4907bef1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddf0e47ee5046a3dd69d01b55aac2a34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72c0a99c75a2c988e4354634bbfa23b4 |
| publicationDate |
2021-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-112348166-A |
| titleOfInvention |
Screening method for sarcopenia based on serum creatinine and cystatin C predicting decreased muscle strength |
| abstract |
The invention discloses a method for screening sarcopenia based on serum creatinine and cystatin C to predict muscle strength decline, and belongs to the field of sarcopenia detection. The invention includes: obtaining serum creatinine and cystatin C; using the ratio of serum creatinine and cystatin C as a marker for screening the reduction of grip strength; constructing and training a relationship model between the ratio of serum creatinine and cystatin C and grip strength; Based on the relational model, the appropriate diagnostic cutoff values of the ratio of serum creatinine and cystatin C for users of different genders are respectively determined; the predicted values in the reduction of grip strength of the corresponding genders are determined according to the appropriate diagnostic cutoff values of users of different genders; according to the predictions value predicts decreased muscle strength. The invention can determine the relationship between the ratio of serum creatinine and cystatin C and grip strength, and identify the situation of reduced grip strength in the crowd through the calculated ratio of serum creatinine and cystatin C, thereby providing accurate information for further detection of sarcopenia. Predicted, greatly reducing the size of the population that needs to be screened for sarcopenia. |
| priorityDate |
2020-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |